Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Clinical trial NCT02635672 · COMPLETED
Trial details
- NCT number
- NCT02635672
- Sponsor
- Vincerx Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-10
- Primary completion
- 2024-11-11
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.